Clinical Trial Update: Ketoprofen 10% Cream for Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue Injury [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Ketoprofen 10% Cream for pain relief in mild-to-moderate acute soft tissue injuries (sprains) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sprain

Drugs mentioned

• Ketoprofen 10% Cream (ketoprofen)

Snippet

Sponsor: Imprimis Pharmaceuticals, Inc. | Conditions: Sprain | Phase 3 | Status: WITHDRAWN